Drug research

Ivonescimab Injection

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514	Summit Therapeutics	Phase 3	Recruiting	2028-04Estimated
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsNCT05899608	Summit Therapeutics	Phase 3	Recruiting	2028-12-31Estimated

Summit TherapeuticsRecruitingPrimary completion: 2028-04 · Estimated

Trial details

Summit TherapeuticsRecruitingPrimary completion: 2028-12-31 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.